Comparing the Effect of Dressing Versus No-dressing on Exit Site Infection and Peritonitis in Chronic Ambulatory Peritoneal Dialysis Patients

Overview

Journal Adv Biomed Res

Specialty Biomedical Engineering

Date 2017 Feb 21

PMID 28217650

Citations 2

Authors

Shahram Taheri

Mahdieh Ahmadnia

Mojgan Mortazavi

Shirin Karimi

Homa Reihani

Shiva Seirafian

Affiliations

Soon will be listed here.

Abstract

Bachground: Peritonitis and exit site (ES) infection are two main complications of peritoneal dialysis. There are some controversies regard to preventive strategies for ES care. In this study we compared peritonitis and ES infection rates in patients with and without dressing.

Materials And Methods: This historical cohort study carried out on 72 patients under continuous ambulatory peritoneal dialysis treatment, 54 with dressing versus 18 patients without dressing, followed from October 1, 2010 to March 31, 2011 for peritonitis and ES infection.

Results: A total of 17 episodes of ES infection occurred in 12 patients in dressing group, but no case was seen in no-dressing group ( = 0.02). Twenty-one episodes of peritonitis occurred in 15 patients in both groups (one episode every 20.6 patient-months). In no-dressing group two episodes occurred in only one patient (one episode every 54 patient-months), and in dressing group, 19 episode in 14 patients (one episode every 17.1 patient-months) ( = 0.03). Peritonitis was significantly more frequent in male versus female in overall patients (38% vs. 14%, = 0.025) and in dressing group (52% vs. 15%, = 0.003). In dressing group, peritonitis was more frequent in diabetics versus non-diabetics (48% vs. 11%, = 0.01). Odds ratio for developing peritonitis was 9.4 in dressing group (95% confidence interval [CI] =1.05 - 84.4; = 0.045), and 4.4 in men (95% CI = 1.26 - 15.19; = 0.02).

Conclusion: In this study, chronic ES care without dressing was associated with lower risk of peritonitis and ES infection.

Citing Articles

An outbreak of complex exit site infection among peritoneal dialysis patients caused by contaminated spray dressing.

Cheng L, Chau S, Chan W, Chen J, Wong B, Fung K Infect Prev Pract. 2024; 6(2):100359.

PMID: 38559368 PMC: 10981104. DOI: 10.1016/j.infpip.2024.100359.

Milan Manani S, Virzi G, Giuliani A, Crepaldi C, Ronco C J Nephrol. 2019; 32(5):837-841.

PMID: 30955154 DOI: 10.1007/s40620-019-00604-3.

References

Danguilan R, Evangelista L, Abrenica M, Rondilla S . Comparative study of mupirocin and sodium fucidate in the prophylaxis of exit-site infections in CAPD patients. Perit Dial Int. 2004; 23(6):593-5. View

Conly J, Vas S . Increasing mupirocin resistance of Staphylococcus aureus in CAPD--should it continue to be used as prophylaxis?. Perit Dial Int. 2003; 22(6):649-52. View

Piraino B, Bernardini J, Bender F . An analysis of methods to prevent peritoneal dialysis catheter infections. Perit Dial Int. 2008; 28(5):437-43. View

Piraino B, Bernardini J, Sorkin M . Catheter infections as a factor in the transfer of continuous ambulatory peritoneal dialysis patients to hemodialysis. Am J Kidney Dis. 1989; 13(5):365-9. DOI: 10.1016/s0272-6386(89)80018-6. View

Bayston R, Andrews M, Rigg K, Shelton A . Recurrent infection and catheter loss in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 2000; 19(6):550-5. View

Prischl F, Arneitz K, Karner A, Artes R, Wolf E, Auinger M . Exit-site care in Austrian peritoneal dialysis centers -- a nationwide survey. Perit Dial Int. 2009; 29(3):330-9. View

Naylor M, Roe B . A study of the efficacy of dressings in preventing infections of continuous ambulatory peritoneal dialysis catheter exit sites. J Clin Nurs. 1997; 6(1):17-24. DOI: 10.1111/j.1365-2702.1997.tb00279.x. View

Bernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L . Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol. 2004; 16(2):539-45. DOI: 10.1681/ASN.2004090773. View

Montenegro J, Saracho R, Aguirre R, Martinez I, Iribar I, Ocharan J . Exit-site care with ciprofloxacin otologic solution prevents polyurethane catheter infection in peritoneal dialysis patients. Perit Dial Int. 2000; 20(2):209-14. View

10.

Zimmerman S, Ahrens E, Johnson C, Craig W, Leggett J, OBrien M . Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections. Am J Kidney Dis. 1991; 18(2):225-31. DOI: 10.1016/s0272-6386(12)80883-3. View

11.

Piraino B . Can we reduce rates of Staphylococcus aureus and other peritonitis in peritoneal dialysis patients?. Perit Dial Int. 2010; 30(3):277-9. DOI: 10.3747/pdi.2010.00052. View

12.

Chua A, Goldstein S, Bell D, Brewer E . Topical mupirocin/sodium hypochlorite reduces peritonitis and exit-site infection rates in children. Clin J Am Soc Nephrol. 2009; 4(12):1939-43. PMC: 2798867. DOI: 10.2215/CJN.02770409. View

13.

Perez-Fontan M, Rosales M, Rodriguez-Carmona A, Garcia Falcon T, Valdes F . Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis. 2002; 39(2):337-41. DOI: 10.1053/ajkd.2002.30553. View

14.

Kam-Tao Li P, Szeto C, Piraino B, Bernardini J, Figueiredo A, Gupta A . Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int. 2010; 30(4):393-423. DOI: 10.3747/pdi.2010.00049. View

15.

Schiffl H, Mucke C, Lang S . Exit-site infections by non-diphtheria corynebacteria in CAPD. Perit Dial Int. 2004; 24(5):454-9. View

16.

Lima R, Barreira A, Cardoso F, Lima M, Leite Jr M . Ciprofloxacin and cefazolin as a combination for empirical initial therapy of peritoneal dialysis-related peritonitis: five-year follow-up. Perit Dial Int. 2006; 27(1):56-60. View

17.

Kavanagh D, Prescott G, Mactier R . Peritoneal dialysis-associated peritonitis in Scotland (1999-2002). Nephrol Dial Transplant. 2004; 19(10):2584-91. DOI: 10.1093/ndt/gfh386. View

18.

Fernandes N, Bastos M, Cassi H, Machado N, Ribeiro J, Martins G . The Brazilian Peritoneal Dialysis Multicenter Study (BRAZPD) : characterization of the cohort. Kidney Int Suppl. 2008; (108):S145-51. DOI: 10.1038/sj.ki.5002616. View

19.

Tanaka S, Yosizawa K, Sakuma M . Keeping the catheter exit site clean by sealing with a dressing film in patients under continuous ambulatory peritoneal dialysis. Adv Perit Dial. 2002; 18:158-60. View

20.

Tse K, Lui S, Cheng V, Yip T, Lo W . A cluster of rapidly growing mycobacterial peritoneal dialysis catheter exit-site infections. Am J Kidney Dis. 2007; 50(1):e1-5. DOI: 10.1053/j.ajkd.2007.04.017. View